Corbus Pharmaceuticals Holdings Inc (CRBP)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Yuval Cohen
Employees:
40
100 RIVER RIDGE DRIVE, NORWOOD, MA 02062
617-963-0103

Corbus Pharmaceuticals Holdings, Inc. focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus. CRB-601, an anti-integrin monoclonal antibody (mAb) that inhibits the activation of transforming growth factor ß (TGFß)

Data derived from most recent annual or quarterly report
Market Cap 36.999 Million Shares Outstanding4.171 Million Avg 30-day Volume 45.346 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-12.21
Price to Revenue0.0 Debt to Equity1.4288 EBITDA-47.017 Million
Price to Book Value1.847 Operating Margin0.0 Enterprise Value9.498 Million
Current Ratio3.194 EPS Growth-0.334 Quick Ratio3.08
1 Yr BETA 1.6574 52-week High/Low 13.17 / 0.1 Profit Margin0.0
Operating Cash Flow Growth-13.6647 Altman Z-Score-12.9726 Free Cash Flow to Firm -29.747 Million
View SEC Filings from CRBP instead.

View recent insider trading info

Corbus Pharmaceuticals Holdings Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CRBP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRBP

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-05-22 by ALTMEYER ANNE
  • 4: filed on 2023-05-22 by JENKINS JOHN KENNETH
  • 4: filed on 2023-05-22 by JACQUES RACHELLE SUZANNE
  • 4: filed on 2023-05-22 by SALZMANN PETER
  • 4: filed on 2023-05-22 by HOLMER ALAN F
  • 4: filed on 2023-05-22 by BEN YONG
  • 4: filed on 2023-05-22 by CATLIN AVERY W
  • 4: filed on 2023-03-07 by BEN YONG
  • 3: filed on 2023-03-07 by BEN YONG
  • 4: filed on 2023-02-15 by BRAKE RACHAEL LOUISE

    • Events (8k)

  • 8-K: filed on 2023-05-19:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2023-04-24:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-07:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2023-02-15:
    Item 3.03: Material Modifications to Rights of Security Holders
  • 8-K: filed on 2023-02-13:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-06:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 8.01: Other Events
  • 8-K: filed on 2022-12-21:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-12-21:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    CATLIN AVERY W

    • Director
    		 0 2023-05-18 1

    HOLMER ALAN F

    • Director
    		 0 2023-05-18 1

    JENKINS JOHN KENNETH

    • Director
    		 0 2023-05-18 1

    JACQUES RACHELLE SUZANNE

    • Director
    		 0 2023-05-18 1

    SALZMANN PETER

    • Director
    		 0 2023-05-18 1

    ALTMEYER ANNE

    • Director
    		 0 2023-05-18 3

    BEN YONG

    • Director
    		 0 2023-05-18 3

    MORAN SEAN F. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-02-13 2

    MILLIAN CRAIG STUART CHIEF OPERATING OFFICER

    • Officer
    		 0 2023-02-13 2

    BRAKE RACHAEL LOUISE CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2023-02-13 1

    COHEN YUVAL CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 98,230 2022-08-10 1

    WHITE BARBARA CHIEF MEDICAL OFFICER

    • Officer
    		 0 2021-02-02 0

    GOLUMBESKI GEORGE

    • Director
    		 0 2020-07-06 0

    HOCHMAN DAVID P

    • Director
    		 0 2020-05-20 0

    DISCORDIA ROBERT PAUL CHIEF OPERATING OFFICER

    • Officer
    		 35,490 2020-03-17 0

    PANAYIOTOPOULOS PARIS

    • Director
    		 0 2019-05-22 0

    TEPPER MARK PRESIDENT AND CSO

    • Officer
    		 0 2019-01-18 0

    GUPTA RENU

    • Director
    		 0 2017-05-25 0

    BURSTEIN SUMNER

    • FORMER 10% HOLDER
    		 No longer subject to file 2015-11-16 0

    KNOLL CAPITAL MANAGEMENT, LP

    • 10% Owner
    		 2,750,000 2014-11-24 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    CATLIN AVERY W - Director

    		2023-05-22 16:17:51 -0400 2023-05-18 A 5,300 a 5,300 direct

    BEN YONG - Director

    		2023-05-22 16:20:49 -0400 2023-05-18 A 5,300 a 5,300 direct

    HOLMER ALAN F - Director

    		2023-05-22 16:22:54 -0400 2023-05-18 A 5,300 a 5,300 direct

    SALZMANN PETER - Director

    		2023-05-22 16:24:56 -0400 2023-05-18 A 5,300 a 5,300 direct

    JACQUES RACHELLE SUZANNE - Director

    		2023-05-22 16:27:28 -0400 2023-05-18 A 5,300 a 5,300 direct

    JENKINS JOHN KENNETH - Director

    		2023-05-22 16:32:16 -0400 2023-05-18 A 5,300 a 5,300 direct

    ALTMEYER ANNE - Director

    		2023-05-22 16:33:59 -0400 2023-05-18 A 5,300 a 5,300 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 22:15:04 UTC -46.1893 51.2493 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 21:45:04 UTC -46.1893 51.2493 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 21:15:03 UTC -46.1893 51.2493 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 20:45:04 UTC -46.1893 51.2493 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 20:15:06 UTC -45.7161 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 19:45:04 UTC -45.7161 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 19:15:21 UTC -45.7161 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 18:45:03 UTC -45.7161 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 18:15:04 UTC -45.7161 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 17:45:03 UTC -45.7161 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 17:15:05 UTC -45.7161 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 16:45:04 UTC -45.7061 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 16:15:04 UTC -45.7061 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 15:45:03 UTC -45.7061 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 15:15:04 UTC -45.7061 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 14:45:04 UTC -45.7061 50.7761 100000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 14:15:03 UTC -45.7061 50.7761 90000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 13:45:04 UTC -25.8501 30.9201 80000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 13:15:04 UTC -25.8501 30.9201 80000
    CORBUS PHARMACEUTICALS HOLDI CRBP 2023-05-31 12:45:04 UTC -25.8501 30.9201 80000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Enhanced Index Plus Fund CRBP -23.0 shares, $-120.52 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund CRBP -31.0 shares, $-162.44 2020-03-31 N-PORT
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CRBP -1009.0 shares, $-7335.43 2023-03-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments